Related Experiment Video
Updated: Aug 9, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure
Maria-Aurora Morales1, Silvia Del Ry, Umberto Startari
1Cardiology and Cardiovascular Biochemistry Laboratory, CNR Institute of Clinical Physiology, Pisa, Italy. morales@ifc.cnr.it
Insights
Increased adrenomedullin (AM) levels correlate with left ventricular (LV) dysfunction severity in heart failure (HF) patients. This finding may help characterize HF progression independently of ejection fraction.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Research
Background:
- Elevated circulating adrenomedullin (AM) is linked to heart failure (HF).
- AM is a potential biomarker for cardiac dysfunction.
Purpose of the Study:
- To investigate the association between AM levels and left ventricular (LV) function in HF patients.
- To evaluate AM as a marker for LV dysfunction severity using echo-Doppler methods.
Main Methods:
- Measured plasma AM, B-type natriuretic peptide (BNP), and N-terminal proBNP in 55 HF patients and 20 controls.
- Calculated dP/dt (rate of pressure rise) from mitral regurgitation jet Doppler tracings.
- Assessed patients across NYHA functional classes I, II, and III.
Main Results:
- AM levels were significantly higher in HF patients than controls and increased with NYHA class.
- dP/dt showed a stronger correlation with AM (r=0.582) than with BNP or NT-proBNP.
- AM levels differed significantly based on dP/dt cut-offs predicting event-free survival.
Conclusions:
- Increased AM, combined with reduced contractility, may help characterize LV dysfunction severity in HF.
- AM's predictive value appears independent of baseline LV ejection fraction.
Background:
Increased circulating adrenomedullin (AM) concentration has been reported in congestive heart failure (HF) and considered as a possible marker of cardiac dysfunction.
Hypothesis:
The study was undertaken to assess the relationship between circulating AM concentration and left ventricular (LV) functional state, estimated by echo-Doppler techniques in patients with mild to moderate HF and different degrees of LV dysfunction.
Methods:
Plasma AM, B-type natriuretic peptide (BNP), and N-terminal (NT) proBNP levels were measured in 55 patients with HF (New York Heart Association [NYHA] I n = 8, II n = 26, III n = 21) and in 20 controls; dP/dt was calculated by the Doppler tracing of the mitral regurgitation jet.
Results:
The study was completed in 51 patients. Adrenomedullin levels were higher than in controls (19.2 +/- 1.4 vs. 13.3 +/- 0.7, p < 0.005) and elevated in proportion to NYHA functional class. B-type natriuretic peptide and NT-proBNP were 344 +/- 67 vs. 12 +/- 2 pg/ml and 2196 +/- 623 vs. 52 +/- 4 pg/ml, respectively (p < 0.0001); dP/dt was better related to AM (r = 0.582, p < 0.001) than to the other peptides. Adrenomedullin was significantly (p < 0.001) different between patients grouped according to the dP/dt cut-off predictive of event-free survival.
Conclusions:
The combination of depressed contractility and increased AM may provide a clue for further characterization of the severity of LV dysfunction in HF, independent of baseline LV ejection fraction.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Mitral Regurgitation I: Introduction
Heart Failure VI: Adjunct Therapies
